GlycoNet’s Associate Director Clinical Partnerships, Dr. Lara Mahal, is bringing personalized health care to reality.
From pioneering carbohydrate synthesis to studying aging and immunity, these GlycoNet researchers are recognized by the country’s oldest and most prestigious scholarly institute.
GlycoNet scientists aim to change the way we diagnose the disease with a new blood test.
Dr. Elizabeth Nanak will take GlycoNet to the next phase of improving the health of Canadians through scientific knowledge and technologies built upon glycoscience.
Edmonton-based biotech 48Hour Discovery is invited to travel to Pangyo Technoo Valley, the Korean version of the Silicon Valley, to expand their technology into the Asian market.
Discovering antiviral and anticancer drugs will soon be faster and cheaper thanks to new research from GlycoNet Investigator Dr. Robert Britton at Simon Fraser University and his international team.
The partnership, funded by NSERC Alliance Grant, will support Dr. Warren Wakarchuk’s work on the role of O-glycans in triggering immune response.
The fund aims to support projects that mitigate the impact of healthcare burden in Canada and contribute to better understanding of challenging diseases.
Dr. Rui Resendes will develop business opportunities and build strategic partnerships to advance Network research priorities.
GlycoNet scientists are searching for ways to weaken bacteria’s ability to develop resistance.